tirzepatide vs semaglutide efficacy weight loss as Compared with for the Treatment of Obesity Tirzepatide led to greater real-world
Description
Notes: Size and dimensions: 29 Gauge 1cc 1/2 inch

Ongoing #GLP1 -RA Trials on #ASCVD #SELECT: Semaglutide vs Placebo in Patients With Obesity and ASCVD Without DM #SOUL: Semaglutide vs Placebo in Adults With T2D With ASCVD or CKD #SURPASS-CVOT: Tirzepatide vs Dulaglutide in Patients With T2D and ASCVD #SURMOUNT-MMO:

All doses of tirzepatide increased the number of achieved standard and intensive targets compared with semaglutide

Black GLP-1 users had an increased risk of all-cause hospitalizations (HR 1.59, CI 1.112.29) but not IBD-related hospitalization or IBD-related surgery
PlexusDx explains the science behind semaglutide timing and how personalized dosing strategies may fit your weight loss goals
